BRISTOL-MYERS SQUIBB CO (BMY) Fundamental Analysis & Valuation

NYSE:BMY • US1101221083

Current stock price

57.66 USD
+0.18 (+0.31%)
Last:

This BMY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. BMY Profitability Analysis

1.1 Basic Checks

  • BMY had positive earnings in the past year.
  • BMY had a positive operating cash flow in the past year.
  • Of the past 5 years BMY 4 years were profitable.
  • BMY had a positive operating cash flow in each of the past 5 years.
BMY Yearly Net Income VS EBIT VS OCF VS FCFBMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • BMY has a better Return On Assets (7.83%) than 88.60% of its industry peers.
  • The Return On Equity of BMY (38.19%) is better than 96.89% of its industry peers.
  • The Return On Invested Capital of BMY (19.52%) is better than 95.85% of its industry peers.
  • BMY had an Average Return On Invested Capital over the past 3 years of 14.47%. This is in line with the industry average of 13.04%.
  • The last Return On Invested Capital (19.52%) for BMY is above the 3 year average (14.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROIC 19.52%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
BMY Yearly ROA, ROE, ROICBMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • BMY has a Profit Margin of 14.64%. This is amongst the best in the industry. BMY outperforms 88.08% of its industry peers.
  • BMY's Profit Margin has improved in the last couple of years.
  • BMY has a Operating Margin of 35.82%. This is amongst the best in the industry. BMY outperforms 96.37% of its industry peers.
  • In the last couple of years the Operating Margin of BMY has grown nicely.
  • BMY has a Gross Margin of 72.63%. This is amongst the best in the industry. BMY outperforms 80.83% of its industry peers.
  • In the last couple of years the Gross Margin of BMY has remained more or less at the same level.
Industry RankSector Rank
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
BMY Yearly Profit, Operating, Gross MarginsBMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BMY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BMY is creating value.
  • BMY has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BMY has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BMY has an improved debt to assets ratio.
BMY Yearly Shares OutstandingBMY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
BMY Yearly Total Debt VS Total AssetsBMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • BMY has an Altman-Z score of 2.49. This is not the best score and indicates that BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of BMY (2.49) is better than 66.84% of its industry peers.
  • BMY has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as BMY would need 3.51 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 3.51, BMY belongs to the best of the industry, outperforming 89.12% of the companies in the same industry.
  • BMY has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
  • BMY has a Debt to Equity ratio of 2.33. This is in the lower half of the industry: BMY underperforms 77.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Altman-Z 2.49
ROIC/WACC2.23
WACC8.76%
BMY Yearly LT Debt VS Equity VS FCFBMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • BMY has a Current Ratio of 1.26. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BMY (1.26) is worse than 76.17% of its industry peers.
  • BMY has a Quick Ratio of 1.14. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BMY (1.14) is worse than 73.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.14
BMY Yearly Current Assets VS Current LiabilitesBMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. BMY Growth Analysis

3.1 Past

  • BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 439.47%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -0.92% on average over the past years.
  • The Revenue has decreased by -0.22% in the past year.
  • The Revenue has been growing slightly by 2.54% on average over the past years.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%

3.2 Future

  • BMY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.15% yearly.
  • BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.54% yearly.
EPS Next Y2.98%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
EPS Next 5Y-4.15%
Revenue Next Year-1.85%
Revenue Next 2Y-1.95%
Revenue Next 3Y-5.42%
Revenue Next 5Y-5.54%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BMY Yearly Revenue VS EstimatesBMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
BMY Yearly EPS VS EstimatesBMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. BMY Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.38, the valuation of BMY can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of BMY indicates a rather cheap valuation: BMY is cheaper than 92.23% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. BMY is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 9.10, the valuation of BMY can be described as reasonable.
  • 88.60% of the companies in the same industry are more expensive than BMY, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.42. BMY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.38
Fwd PE 9.1
BMY Price Earnings VS Forward Price EarningsBMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BMY is valued cheaper than 93.26% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BMY indicates a rather cheap valuation: BMY is cheaper than 90.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.14
EV/EBITDA 7.09
BMY Per share dataBMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BMY does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of BMY may justify a higher PE ratio.
  • BMY's earnings are expected to decrease with -4.05% in the coming years. This may justify a cheaper valuation.
PEG (NY)3.15
PEG (5Y)N/A
EPS Next 2Y0.29%
EPS Next 3Y-4.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. BMY Dividend Analysis

5.1 Amount

  • BMY has a Yearly Dividend Yield of 4.34%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.79, BMY pays a better dividend. On top of this BMY pays more dividend than 96.37% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, BMY pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.34%

5.2 History

  • The dividend of BMY is nicely growing with an annual growth rate of 6.51%!
  • BMY has paid a dividend for at least 10 years, which is a reliable track record.
  • BMY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.51%
Div Incr Years3
Div Non Decr Years3
BMY Yearly Dividends per shareBMY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • BMY pays out 71.52% of its income as dividend. This is not a sustainable payout ratio.
  • BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
BMY Yearly Income VS Free CF VS DividendBMY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B
BMY Dividend Payout.BMY Dividend Payout, showing the Payout Ratio.BMY Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BMY Fundamentals: All Metrics, Ratios and Statistics

BRISTOL-MYERS SQUIBB CO

NYSE:BMY (3/23/2026, 10:54:09 AM)

57.66

+0.18 (+0.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners83.3%
Inst Owner Change1.17%
Ins Owners0.02%
Ins Owner Change2.88%
Market Cap117.42B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target62.03 (7.58%)
Short Float %1.65%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield 4.34%
Yearly Dividend2.51
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years3
Div Non Decr Years3
Ex-Date04-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)6.85%
PT rev (3m)15.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.97%
EPS NY rev (1m)4.07%
EPS NY rev (3m)3.91%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)1.92%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)6.95%
Valuation
Industry RankSector Rank
PE 9.38
Fwd PE 9.1
P/S 2.44
P/FCF 9.14
P/OCF 8.29
P/B 6.36
P/tB N/A
EV/EBITDA 7.09
EPS(TTM)6.15
EY10.67%
EPS(NY)6.33
Fwd EY10.98%
FCF(TTM)6.31
FCFY10.94%
OCF(TTM)6.95
OCFY12.06%
SpS23.67
BVpS9.07
TBVpS-10.99
PEG (NY)3.15
PEG (5Y)N/A
Graham Number35.43
Profitability
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROCE 25.91%
ROIC 19.52%
ROICexc 23.22%
ROICexgc 84.94%
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
FCFM 26.65%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Debt/EBITDA 2.03
Cap/Depr 32.69%
Cap/Sales 2.72%
Interest Coverage 8.22
Cash Conversion 66.54%
Profit Quality 182.1%
Current Ratio 1.26
Quick Ratio 1.14
Altman-Z 2.49
F-Score7
WACC8.76%
ROIC/WACC2.23
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y2.98%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
EPS Next 5Y-4.15%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.85%
Revenue Next 2Y-1.95%
Revenue Next 3Y-5.42%
Revenue Next 5Y-5.54%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.47%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%

BRISTOL-MYERS SQUIBB CO / BMY Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BRISTOL-MYERS SQUIBB CO (BMY) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BMY.


What is the valuation status for BMY stock?

ChartMill assigns a valuation rating of 8 / 10 to BRISTOL-MYERS SQUIBB CO (BMY). This can be considered as Undervalued.


What is the profitability of BMY stock?

BRISTOL-MYERS SQUIBB CO (BMY) has a profitability rating of 9 / 10.


Can you provide the financial health for BMY stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (BMY) is 5 / 10.


What is the expected EPS growth for BRISTOL-MYERS SQUIBB CO (BMY) stock?

The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BMY) is expected to grow by 2.98% in the next year.